Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study
Table 3
Spearman’s/Pearson’s correlations between clinical, demographic, and cognitive variables and plasma BDNF concentrations in MNCD-AD and ScVMNCD groups.